The YTHDC1-m6A-GADD45B axis promotes chondrogenesis of hPDLSCs via suppressing senescence through p53/p21 signalling pathway Authors: Dan Tan, Qianke Tao, Luwen Ye, Xuemei Long, Qiaonan Ye, Qilin Li, Jinlin Song, Jingang Xiao Published: 2026 ABSTRACT AbstractTemporomandibular joint osteoarthritis (TMJOA) is a degenerative disease with limited therapeutic options. Stem cell-based tissue engineering, particularly utilizing human periodontal ligament stem cells (hPDLSCs), represents a promising approach for cartilage regeneration. However, we have previously demonstrated that chronic inflammation and hypoxic stress in the TMJOA microenvironment markedly accelerate cellular senescence in hPDLSCs, severely impairing their regenerative potential. Here, we identify the YTHDC1–m⁶A–GADD45B axis as a critical regulator of senescence and chondrogenic differentiation in hPDLSCs. We show that YTHDC1, an m⁶A reader protein, is downregulated under inflammatory and senescent conditions. Functional studies reveal that YTHDC1 overexpression attenuates senescence and enhances chondrogenesis, whereas its knockdown exacerbates senescence and suppresses differentiation. Mechanistically, YTHDC1 recognizes m⁶A modifications on GADD45B mRNA and promotes its decay, leading to inhibition of the p53/p21 signaling pathway. Mutation of the m⁶A site in GADD45B abolishes the regulatory effects of YTHDC1. In rats with TMJOA, transplantation of YTHDC1–overexpressing hPDLSCs ameliorated disease phenotypes, an effect reversed by co-expression of wild-type GADD45B. Our findings reveal a novel epitranscriptomic mechanism that regulates hPDLSCs senescence and subsequently affects chondrogenic differentiation, and highlight the therapeutic potential of targeting the YTHDC1-GADD45B-p53/p21 axis.Subject terms: Malocclusion, Stem-cell differentiation Introduction Temporomandibular joint osteoarthritis (TMJOA) is a progressive degenerative disorder and a common end-stage manifestation of temporomandibular disorders (TMDs).1 It is characterized by articular cartilage degradation, subchondral bone sclerosis, and condylar bone destruction.2 Histopathological features include disorganized trabecular architecture, erosive bone resorption, aberrant bone remodeling, and osteophyte formation. Clinically, TMJOA presents with joint pain, restricted mandibular movement, and audible joint sounds.1,3 Epidemiological studies suggest that TMDs affect approximately 20%–40% of the global population, with about 14.56% of these cases progressing to radiographically confirmed TMJOA.1,4 Given the population size of China, it is estimated that over 40 million individuals are affected by TMJOA, representing a substantial public health burden. Articular cartilage, a highly specialized avascular and aneural tissue, possesses limited intrinsic regenerative capacity.2,5,6 This inherent constraint often renders TMJOA-induced cartilage damage irreversible, posing a major challenge for regenerative therapies.4,7 Stem cell-based tissue engineering has emerged as a promising strategy for cartilage repair.8–12 Among various candidate cell types, human periodontal ligament stem cells (hPDLSCs) offer distinct advantages, including accessibility (e.g., from extracted wisdom teeth or orthodontic procedures), abundant supply, minimal harvest morbidity, stable genomic features, and strong proliferative and multilineage differentiation potential.13 However, the pathological microenvironment of TMJOA, marked by chronic inflammation and hypoxia, is a well-established driver of cellular senescence.14,15 We therefore hypothesized that this environment would also impair the function of transplanted hPDLSCs. Senescent hPDLSCs exhibit not only reduced proliferation but also significantly diminished chondrogenic potential, which critically impairs their efficacy in regenerative applications.16 Therefore, elucidating the molecular mechanisms underlying TMJOA microenvironment-induced hPDLSCs senescence and developing targeted interventions are essential for advancing stem cell-based therapies for TMJOA. N6-methyladenosine (m6A), the most prevalent internal chemical modification in eukaryotic mRNAs, is dynamically regulated by writers (methyltransferases), erasers (demethylases), and readers (recognition proteins).17–19 The pathological microenvironment (e.g., inflammatory stress) is known to reshape the cellular m6A epitranscriptome, influencing cell fate decisions.20,21 The nuclear m6A reader YTHDC1, a key decoder of m6A signals, has recently been implicated in regulating stem cell fate, including the maintenance of pluripotency and the activation of adult stem cells.17,22,23 Crucially, emerging evidence suggests that YTHDC1 itself can be regulated by inflammatory and stress signals, positioning it as a potential mediator translating pathological microenvironments into altered stem cell behavior.24,25 Nonetheless, its function in the context of TMJOA and in hPDLSCs senescence and chondrogenic differentiation remains unexplored. Growth arrest and DNA damage-inducible beta (GADD45B), a stress-responsive protein, participates in cell cycle control, DNA repair, and senescence.26 It is a well-known downstream effector of inflammatory and stress signaling pathways, such as NF-κB, and can instigate senescence via the p53/p21 axis.26,27 Importantly, its expression or function has been implicated in the pathogenesis of osteoarthritis, underscoring its relevance in joint degeneration.28 This makes GADD45B a plausible candidate linking the TMJOA pathological microenvironment to hPDLSCs dysfunction. Based on the above considerations, we postulated that YTHDC1, as an environment-sensitive m6A reader, might play a pivotal role in regulating hPDLSCs fate under TMJOA-like pathological conditions. To identify the key downstream effector through which YTHDC1 might exert this regulation, we employed an integrated multi-omics approach (RNA-seq combined with RIP-seq). This analysis pinpointed GADD45B as a prime candidate: it was significantly downregulated upon YTHDC1 overexpression, directly bound by YTHDC1, and bioinformatically localized at the intersection of stress response and cellular senescence pathways. This study elucidates the role of the YTHDC1–m⁶A–GADD45B axis in regulating the cell fate of hPDLSCs. We demonstrate that YTHDC1 recognizes and binds m⁶A modifications on GADD45B mRNA, promoting its decay. The subsequent downregulation of GADD45B suppresses the p53/p21 signaling axis, thereby attenuating cellular senescence and liberating the chondrogenic differentiation capacity of hPDLSCs. These findings not only provide mechanistic insight into how YTHDC1 influences hPDLSCs fate, but also highlight a promising therapeutic target for TMJOA. Results Primary culture and three-dimensional chondrogenic induction of hPDLSCs In this study, hPDLSCs were isolated from the periodontal ligament tissues of healthy premolars and third molars obtained from informed consent donors. All procedures were conducted in accordance with the ethical guidelines approved by the Ethics Committee of Southwest Medical University. Phase-contrast microscopy revealed that the isolated cells exhibited a characteristic long-spindle morphology with tapered ends, consistent with the typical appearance of mesenchymal stem cells (MSCs) (Supplementary Fig. S1a). To further validate their stem cell identity, multilineage differentiation potential was assessed. Following two weeks of osteogenic induction, alkaline phosphatase (ALP) activity was significantly elevated, and Alizarin Red S (ARS) staining confirmed extensive mineralization nodule formation. After three weeks of adipogenic induction, Oil Red O staining revealed abundant lipid droplet accumulation. Additionally, upon chondrogenic induction, Alcian Blue staining demonstrated robust deposition of sulfated proteoglycans, a hallmark of cartilaginous matrix formation. These results confirm that the isolated hPDLSCs possess the multipotent differentiation capacity inherent to MSCs (Supplementary Fig. S1b). To better mimic the in vivo microenvironment—a limitation of conventional 2D culture—we performed three-dimensional (3D) chondrogenic induction using a centrifuge tube system supplemented with Matrigel® as a natural extracellular matrix scaffold. After 19–22 days of induction, well-defined cartilage spheroids (approximately 1 mm in diameter) were formed (Supplementary Fig. S1c). These spheroids exhibited structural characteristics resembling native cartilage tissue, providing a more physiologically relevant model for simulating stem cell behavior within the temporomandibular joint space compared to 2D cultures. Flow cytometric analysis demonstrated high expression of classic MSC surface markers—CD29, CD44, and CD105—along with negligible expression of hematopoietic markers CD34, CD45 and CD31(Supplementary Fig. S1d). This immunophenotypic profile is consistent with the minimal criteria for MSC definition established by the International Society for Stem Cell Research (ISSCR). YTHDC1 expression is dynamically regulated during chondrogenic differentiation and under inflammatory senescent conditions in hPDLSCs During the early phase of chondrogenic induction (Day 2 and Day 7), m6A dot blot analysis revealed a time-dependent increase in global m6A methylation levels (Fig. 1a). This elevated m6A modification is accompanied by alterations in the expression of key m6A-modifying enzymes. Concurrently, qPCR results demonstrated significant upregulation of core chondrogenic markers—SOX9, a master regulator of chondrogenesis, and COL2A1, a major cartilage-specific collagen (Fig. 1b). Extended profiling (Fig. S2a) further revealed coordinated changes in the expression of key m⁶A regulatory factors during this reprogramming. Specifically, the writer complex components METTL14 and WTAP were significantly upregulated, whereas the eraser ALKBH5 increased only modestly, and the cytoplasmic readers YTHDF1 and YTHDF2 remained largely unchanged. Notably, transcriptional expression of the nuclear m⁶A reader YTHDC1, which mediates m⁶A-dependent RNA processing, also showed a marked and progressive increase. Immunofluorescence staining further validated the temporal upregulation of both YTHDC1 and chondrogenic markers at the protein level (Fig. 1c, d and Fig. S2b). These coordinated changes suggest that YTHDC1 may serve as a functional component within the m6A regulatory system during chondrogenic differentiation of hPDLSCs. YTHDC1 expression is upregulated during chondrogenic differentiation of hPDLSCs but downregulated under inflammatory senescence. a Dot blot analysis of m6A levels at days 2 and 7 of chondrogenic induction (MB staining as loading control). b qPCR analysis of YTHDC1, chondrogenic markers (SOX9, COL2A1), and m6A modifiers during chondrogenic induction. c, d Immunofluorescence staining of SOX9 and YTHDC1 at days 2 and 7 of chondrogenic induction. Scale bar, 20 µm. e qPCR analysis of YTHDC1, senescence markers (p16, p21, TP53, IL-1β), and SOX9 under normal or inflammatory conditions. f Western blot analysis of YTHDC1, senescence markers (p53, p21, p16), and SOX9 protein levels under inflammatory conditions. Data are presented as mean ± SEM; n = 3; *P < 0.05, **P < 0.01, ***P < 0.001,****P < 0.000 1 To simulate the inflammatory microenvironment, both hPDLSCs and chondrocytes were co-cultured in medium supplemented with a cytokine cocktail containing 20 ng/mL recombinant human TNF-α (PeproTech, catalog #300-01 A) and 10 ng/mL recombinant human IFN-γ (PeproTech, catalog #300-02). The cytokines were added simultaneously at the initiation of the co-culture and were present continuously in the medium throughout the entire 5-day experiment, with the medium (including fresh cytokines) replaced every 48 h.5,29 Phenotypic assessment performed after 5 days of co-culture in normal versus inflammatory media revealed a significant downregulation of YTHDC1 in the inflammatory group compared with the control group. Concurrently, the mRNA levels of senescence-associated genes (CDKN2A/p16, CDKN1A/p21, and TP53/p53) and the protein levels of p16, p21, and p53 were significantly upregulated, while the mRNA levels of chondrogenic markers (SOX9, COL2A1) and their corresponding proteins were notably downregulated (Fig. 1e, f and Fig. S2c). Correspondingly, senescence-associated β-galactosidase activity increased, and staining assays related to cell differentiation—including ARS, ALP, and Alcian Blue—marked attenuation under inflammatory conditions (Fig. S2d, e). These results reveal opposite expression trends of YTHDC1 in association with the senescent/inflammatory state and the chondrogenic program, respectively, suggesting its potential involvement in these processes. YTHDC1 regulates senescence and chondrogenic differentiation in hPDLSCs To elucidate the role of YTHDC1 in regulating chondrogenic differentiation and cellular senescence in hPDLSCs, we first performed siRNA-mediated knockdown of YTHDC1 using specific small interfering RNAs, with a scrambled siRNA serving as the negative control. Efficient knockdown (≥70% reduction at mRNA levels) was confirmed by qPCR. YTHDC1 knockdown led to: (1) significant downregulation of key chondrogenic markers (SOX9 and COL2A1); and (2) notable upregulation of senescence-associated markers p21 (CDKN1A) and p16 (CDKN2A), along with a marked increase in senescence-associated β-galactosidase (SA-β-gal) staining. (Fig. 2). YTHDC1 knockdown promote senescence and inhibit chondrogenic differentiation. a qPCR analysis of chondrogenic (SOX9, COL2A1) and senescence markers (p16, p21) after YTHDC1 knockdown. b Western blot analysis of YTHDC1, senescence (p21, p16), and chondrogenic markers (SOX9, COL2A1) protein levels in control and YTHDC1-knockdown hPDLSCs. c, d Immunofluorescence staining showing SOX9, p16, and COL2A1 expression in control and YTHDC1-knockdown hPDLSCs (Scale bar: 20 µm). e SA-β-gal staining in control and YTHDC1-knockdown cells. Data are mean ± SEM; n = 3; *P < 0.05, **P < 0.01, ***P < 0.001,****P < 0.000 1 To further validate these observations, we established a YTHDC1 overexpression model via a lentiviral delivery system, using an empty vector (EV) as the control. qPCR and Western blot confirmed successful overexpression, as evidenced by significantly elevated mRNA and protein levels compared with the EV group. Overexpression of YTHDC1 resulted in: (1) significantly reduced mRNA expression of senescence markers CDKN2A/p16 and CDKN1A/p21, along with a marked decrease in senescence-associated β-galactosidase (SA-β-gal) staining; and (2) markedly enhanced expression of chondrogenic markers SOX9 and COL2A1 at the mRNA level. These results were consistently corroborated by immunofluorescence staining and Western blot analysis (Fig. 3). YTHDC1 overexpression inhibits senescence and promotes chondrogenic differentiation. a qPCR analysis of senescence and chondrogenic markers (p16, p21, SOX9, COL2A1) after YTHDC1 overexpression. b Western blot analysis of YTHDC1, senescence (p21, p16), and chondrogenic markers (SOX9, COL2A1) in control and YTHDC1-overexpressing hPDLSCs. c, d Immunofluorescence staining of SOX9, p16, and COL2A1 in control and YTHDC1-overexpressing hPDLSCs (Scale bar: 20 µm). e SA-β-gal staining in indicated cells (Scale bar: 200 µm). Data are mean ± SEM; n = 3; *P < 0.05, **P < 0.01, ***P < 0.001,****P < 0.000 1 To better mimic the in vivo microenvironment, we employed a 3D chondrogenic induction system to assess the functional role of YTHDC1. After 30 days of culture, YTHDC1-overexpressing cells formed larger cartilage spheroids with morphology and structure more closely resembling native cartilage compared to controls (Fig. 4a). Histological analysis using safranin O-fast green staining revealed enhanced proteoglycan deposition, higher glycosaminoglycan (GAG) content, and more distinct chondrocyte lacunae in the YTHDC1-overexpression group (Fig. 4b and Fig. S3a). Immunohistochemical staining further showed a significantly increased proportion of COL2A1-positive cells in YTHDC1-overexpressing spheroids (Fig. 4b and Fig. S3a). Together, these data indicate that YTHDC1 robustly promotes chondrogenic differentiation of hPDLSCs under 3D culture conditions. YTHDC1 overexpression enhances chondrogenic differentiation in 3D culture. a Macroscopic morphology of chondrospheres from YTHDC1-overexpressing and control groups after 10 and 20 days of 3D chondrogenic induction. Scale bar, 1 mm. Quantitative measurements of diameter and weight after 30 days of induction are shown. b Histological analysis via H&E, Alcian Blue, and Safranin O staining, and immunohistochemical (IHC) detection of extracellular matrix components. (Scale bar: 50 µm). Data are presented as mean ± SEM; n = 3; **P < 0.01, ****P < 0.000 1 In summary, combined with the knockdown results, our findings demonstrate that YTHDC1 pleiotropically modulates hPDLSCs function by attenuating cellular senescence and enhancing chondrogenic differentiation, highlighting its critical role as a regulatory node in hPDLSCs biology. YTHDC1 inhibits p53 signaling and attenuates cellular senescence by directly targeting GADD45B To elucidate the molecular mechanism by which YTHDC1 mitigates cellular senescence and enhances the chondrogenic potential of hPDLSCs, an integrated multi-omics strategy combining RNA sequencing (RNA-seq) and RNA immunoprecipitation sequencing (RIP-seq) was employed. Data indicate that YTHDC1 regulates GADD45B expression, thereby modulating p53-mediated senescence and promoting chondrogenic differentiation. Analysis of differentially expressed genes revealed that GADD45B was significantly downregulated upon YTHDC1 overexpression (Fig. S4a). KEGG pathway analysis of the transcriptomic data further demonstrated that this alteration was associated with a broader functional impact, showing significant enrichment of both the p53 signaling and cellular senescence pathways (Fig. S4b). Integrated analysis of RNA-seq and RIP-seq data pinpointed GADD45B as a direct target of YTHDC1 and a common regulatory node connecting these two pathways (Fig. S4c). Consistently, Gene Set Enrichment Analysis (GSEA) confirmed the coordinated suppression of senescence- and p53-related gene sets (Fig. S4d), and a heatmap visualization illustrated the concurrent downregulation of GADD45B alongside core genes of both pathways (Fig. S4e). At the molecular interaction level, RIP-seq analysis identified YTHDC1-bound transcripts functionally linked to senescence (e.g., GADD45B, BUB1B, MYC) and the p53 pathway (e.g., SIAH1, GADD45B, BCL2), with GADD45B emerging as a shared target (Fig. S4f). Together, these results establish that YTHDC1 represses the p53 signaling and cellular senescence pathways by directly targeting and downregulating GADD45B, supporting a model wherein YTHDC1 directly binds GADD45B mRNA, leading to its downregulation, which in turn suppresses p53 signaling and attenuates cellular senescence in hPDLSCs. YTHDC1 recognizes m6A modifications in the 3’UTR of GADD45B mRNA to regulate its stability and expression The regulatory relationship between YTHDC1 and GADD45B was first examined. qPCR and Western blot analysis revealed that YTHDC1 knockdown significantly increased GADD45B mRNA and protein levels, while YTHDC1 overexpression markedly decreased them (Fig. S3b, c), indicating that YTHDC1 negatively regulates GADD45B expression. Given that YTHDC1 functions as an m6A reader, it was hypothesized that YTHDC1 directly binds to m6A-modified GADD45B mRNA to mediate this repressive effect. To test this, their interaction was first confirmed. RNA immunoprecipitation-quantitative PCR (RIP-qPCR) revealed significant enrichment of GADD45B mRNA in the YTHDC1 immunoprecipitation complex (Fig. 5a). This direct binding was further corroborated by an RNA pull-down assay, showing that GADD45B mRNA specifically pulled down YTHDC1 protein (Fig. 5b). YTHDC1 recognizes m6A modifications in the 3’UTR of GADD45B mRNA to regulate its stability and expression. a RIP-qPCR analysis showing significant enrichment of GADD45B mRNA in YTHDC1 immunoprecipitates. b RNA pull-down assay confirms direct binding between YTHDC1 protein and GADD45B mRNA. c mRNA decay assay using Actinomycin D demonstrates reduced half-life of GADD45B mRNA upon YTHDC1 overexpression. d Predicted m6A modification sites in GADD45B mRNA predicted via the SRAMP website. e MeRIP-qPCR shows time-dependent increase in m6A modification levels of GADD45B during chondrogenic induction. f, g Dual-luciferase reporter assays with wild-type (WT) and mutant (Mut1–3) GADD45B 3’UTR constructs. YTHDC1 overexpression suppresses luciferase activity of WT but not Mut3 (m6A site CDS-1193 mutant). Data are presented as mean ± SEM; n = 3; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.000 1 Whether YTHDC1 affects GADD45B mRNA stability was next explored. Following transcriptional inhibition with actinomycin D, mRNA decay assays revealed that YTHDC1 overexpression significantly shortened the half-life of GADD45B mRNA (Fig. 5c), suggesting that YTHDC1 promotes GADD45B mRNA degradation, consistent with its negative regulatory role observed in Fig. S3b, c. To investigate the m6A-dependent mechanism, RIP-seq data were integrated with predictions from the SRAMP online tool, and conserved m6A modification sites within the GADD45B transcript were identified (Fig. 5d and Fig. S3d). Methylated RNA immunoprecipitation qPCR (MeRIP-qPCR) showed that m6A modification levels of GADD45B mRNA increased in a time-dependent manner during chondrogenic induction (Fig. 5e), implicating m6A in the dynamic regulation of GADD45B. To pinpoint the functional m6A site responsible for YTHDC1 binding and its destabilizing effect, luciferase reporters were constructed containing either the wild-type (WT) 3’UTR of GADD45B or mutant versions (Mut1–Mut3) with site-specific m6A motif disruptions. Dual-luciferase assays demonstrated that YTHDC1 overexpression significantly suppressed the luciferase activity of the WT reporter, an effect that was markedly alleviated in the Mut3 reporter, which carries a mutation at a key m6A site (adenosine 1193) in the 3’UTR (Fig. 5f, g). These results indicate that YTHDC1 specifically recognizes the m6A modification at position 1193 in the GADD45B 3’UTR to mediate mRNA destabilization and degradation, thereby negatively regulating GADD45B expression. YTHDC1 modulates the p53/p21 pathway by targeting GADD45B at adenosine 1193 to control cellular senescence and chondrogenesis To delineate the functional hierarchy of the YTHDC1–m⁶A–GADD45B axis in modulating p53 signaling, cellular senescence, and chondrogenic differentiation in hPDLSCs, we conducted a series of rescue experiments using four genetically modified hPDLSCs populations: ① control (YTHDC1 negative control + empty vector; YTHDC1-NC + EV); ② YTHDC1 overexpression (YTHDC1-OE + EV); ③ wild-type rescue (YTHDC1-OE + GADD45B wild-type overexpression; GADD45B-WT-OE, retaining the m⁶A site at position 1193); and ④ mutant rescue (YTHDC1-OE + GADD45B mutant overexpression; GADD45B-MUT-OE, with a point mutation (A-to-T) at the m⁶A site (position 1193)). Quantitative real-time PCR (qPCR) analysis revealed the following: For senescence-related markers: YTHDC1 overexpression significantly reduced mRNA levels of p53 signaling and senescence markers (CDKN2A/p16, CDKN1A/p21, and TP53/p53) compared to the control. This suppression was partially reversed in the wild-type rescue group. In contrast, the mutant rescue group showed no significant difference in the expression of these markers relative to the YTHDC1-OE group (P > 0.05) (Fig. S5a). For chondrogenic differentiation markers: YTHDC1-OE markedly elevated mRNA expression of SOX9 and COL2A1 compared to controls. This enhancement was partially attenuated in the wild-type rescue group. However, the mutant rescue group exhibited no significant difference in chondrogenic marker expression compared to the YTHDC1-OE group (P > 0.05) (Fig. S5a). Together, these results demonstrate that the m⁶A modification at position 1193 of GADD45B is critical for YTHDC1-mediated suppression of the p53 pathway. These findings were corroborated by multiple complementary approaches: western blot analysis (Fig. 6a, Fig. S5d), immunohistochemical staining of cartilage spheroids, and senescence-associated β-galactosidase (SA-β-gal) staining (Fig. 6b and Fig. S5b), cellular immunofluorescence (Fig. S5c). All methodologies consistently indicated that YTHDC1’s regulatory influence depends functionally on the m⁶A site within GADD45B. YTHDC1 modulates the p53/p21 pathway by targeting GADD45B at adenosine 1193 to regulate cellular senescence and chondrogenesis. a Western blot analysis of senescence and chondrogenic markers in four groups. b SOX9 immunohistochemistry and SA-β-gal staining of cartilage pellets from four groups after 3D chondrogenic induction (Scale bar: 200 µm). Data are mean ± SEM; n = 3 Collectively, these data demonstrate that YTHDC1 governs p53 activation, senescence, and chondrogenic differentiation through m⁶A-dependent targeting of GADD45B. Disruption of this specific m⁶A site eliminates YTHDC1-mediated regulation, highlighting both the functional specificity and mechanistic essentiality of this epitranscriptional cascade. Targeting the YTHDC1–GADD45B–p53 axis ameliorates TMJOA by rejuvenating hPDLSCs To validate the therapeutic potential of the YTHDC1–GADD45B–p53 axis, we employed a rat model of TMJOA induced by unilateral anterior crossbite (UAC) (Fig. S6a). After 8 weeks, the TMJOA group exhibited severe joint degeneration compared to controls, including surface erosion, osteophyte formation, and subchondral bone defects (Fig. S6b, c). Histological analysis confirmed proteoglycan loss, collagen disorganization, and synovitis (Fig. S6d). Quantitative micro-CT and histological scoring (OARSI) confirmed significant deterioration of bone and cartilage structure in TMJOA joints (Fig. S6e, f). We then intervened with engineered hPDLSCs four weeks post-UAC induction (n = 5 per group). Micro-CT analysis revealed that transplantation of YTHDC1-overexpressing hPDLSCs (YTHDC1-OE) effectively rescued bone loss and restored trabecular microstructure. This therapeutic effect was abolished by co-expression of wild-type GADD45B (GADD45B-WT), but not by an m⁶A-site mutant (GADD45B-MUT), confirming the axis specificity (Fig. 7a and Fig. S7a, c). In vivo therapeutic validation of the YTHDC1–GADD45B–p53 axis in a TMJOA repair model. a Representative three-dimensional micro-CT reconstruction images of the temporomandibular joint from each of the six experimental groups (Scale bar: 1 mm) Consistently, special staining of sections from all six experimental groups demonstrated that, compared to the Vector control, YTHDC1-OE treatment preserved rat cartilage integrity, maintained proteoglycan content, and restored normal collagen architecture, as evidenced by H&E, Masson stainning, and Sirius Red staining (Fig. 8a). Semi-quantitative analysis confirmed this significant improvement, which was attenuated by GADD45B-WT but unaffected by GADD45B-MUT (Fig. 8b). In vivo histological evaluation of YTHDC1–GADD45B–p53 axis-targeted therapy in a TMJOA repair model. a Representative histological sections of temporomandibular joints from 6 groups. Staining includes hematoxylin and eosin (H&E), Safranin O–Fast Green, and Picrosirius Red. In the UAC + PBS group, evident cartilage defects (yellow arrows) are observed. All stem cell-treated groups exhibited varying degrees of cartilage repair, with the most pronounced restoration of cartilage structure and tidemark (black dashed line) occurring in the OE-YTHDC1 and OE-YTHDC1 + Mut-GADD45B groups (Scale bar: 1 mm). b Quantitative analysis of histological features in the temporomandibular joints. Data are presented as mean ± SEM; n = 5; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.000 1 To further validate the molecular consistency of our proposed axis in vivo, we performed immunohistochemical (IHC) analysis on joint tissues. The results demonstrated that YTHDC1-OE treatment significantly upregulated the expression of the chondrogenic markers SOX9 and COL2A1, while concurrently increasing YTHDC1 and decreasing GADD45B protein levels in the articular cartilage (Fig. 9 and Fig. S7b). Semi-quantitative analysis of IHC staining intensities confirmed these trends across experimental groups (Fig. S7d). These in vivo molecular findings are consistent with our in vitro data, reinforcing that the therapeutic benefits are mediated through the YTHDC1-GADD45B axis. In vivo immunohistochemical analysis of the YTHDC1–GADD45B axis in TMJOA cartilage. Representative IHC staining of rat TMJ articular cartilage for YTHDC1, chondrogenic markers (COL2A1), and GADD45B. Scale bars represent 1 mm and 200 μm, respectively In vivo, the YTHDC1–GADD45B–p53 axis ameliorates TMJOA pathology through a dual mechanism: (1) suppression of p53-mediated senescence to preserve progenitor cell function, and (2) enhancement of chondrogenic differentiation in hPDLSCs to promote matrix synthesis and repair. The dependence on the m⁶A modification of GADD45B underscores the specificity of this regulatory axis, highlighting its therapeutic potential for TMJOA. The efficacy of stem cell therapy is often limited by the diseased microenvironment. In TMJOA, we identify the senescence of transplanted hPDLSCs as a critical barrier. Here, we delineate a protective pathway in which the m⁶A reader YTHDC1 specifically recognizes and binds to the m⁶A modification at site A1193 on GADD45B mRNA to promote its decay, thereby suppressing the p53/p21 signaling cascade and cellular senescence (Fig. 10). Leveraging this mechanism, we demonstrate that YTHDC1-engineered hPDLSCs markedly alleviate TMJOA in a rat model. Our findings unveil a precise regulatory axis for stem cell-based regeneration, highlighting the therapeutic potential of targeting RNA methylation to overcome senescence-driven therapeutic failure. Schematic model depicting the YTHDC1-m⁶A-GADD45B axis in combating hPDLSC senescence for TMJOA therapy Discussion TMJOA represents an end-stage degenerative disease with limited treatment options, largely due to the poor self-repair capacity of articular cartilage.1–5,9–11,14,15 Stem cell-based therapies, particularly using hPDLSCs, offer a promising avenue for orofacial regeneration.13,30,31 However, their therapeutic potential is severely compromised by the senescence-inducing pathological microenvironment of TMJOA.3,5,16,32 Here, we identify the m⁶A reader YTHDC1 as a central regulator that counteracts senescence and licenses the chondrogenic capacity of hPDLSCs, thereby revealing a targetable axis for TMJOA intervention. We found that chondrogenic differentiation of hPDLSCs is associated with dynamic epitranscriptomic reprogramming, characterized by a global increase in m⁶A levels and a marked upregulation of YTHDC1. This shift involved the coordinated induction of multiple writers (METTL3, METTL14, WTAP) alongside the eraser FTO, suggesting an accelerated m⁶A turnover rate conducive to transcriptome remodeling. The net gain in m⁶A likely results from both enhanced writer activity and the specific functional interpretation by induced readers, most notably the nuclear reader YTHDC1. In stark contrast, the pathological TMJOA microenvironment suppressed YTHDC1 expression while inducing senescence. This inverse correlation positions YTHDC1 loss as a potential driver of hPDLSC dysfunction, aligning with established links between m⁶A dysregulation and aging.25,33–35 A key mechanistic breakthrough was the identification of GADD45B as a critical downstream target of YTHDC1. GADD45B is a well-established mediator of stress-induced senescence and cell cycle arrest.26,27,36–39 Our mechanistic data reveal that YTHDC1 specifically recognizes m⁶A sites on GADD45B mRNA and promotes its degradation, thus acting as a brake on a potent senescence pathway. This function—attenuating GADD45B to suppress p53/p21 signaling—effectively shields hPDLSCs from senescence and liberates their chondrogenic differentiation capacity. Our rescue experiments establish GADD45B as a dominant effector mediating YTHDC1’s functions; whether GADD45B overexpression alone is sufficient to induce senescence and inhibit chondrogenesis in naïve hPDLSCs remains an interesting question for future investigation. This finding adds a crucial layer to the understanding of how stem cells maintain their functional integrity under stress, highlighting a direct link between the epitranscriptome and a core senescence machinery. Our findings resonate with the established importance of m⁶A modifications and reader proteins in stem cell biology.40–45 The critical role of YTHDC1 in maintaining cell identity is underscored by studies showing its loss can alter pluripotent states in embryonic stem cells,17 and its function in regulating mRNA processing is crucial for muscle stem cell activation.23 However, our work distinctively establishes a direct link between YTHDC1 and the control of a specific senescence pathway (GADD45B-p53) in adult somatic stem cells, providing novel insight into the post-transcriptional maintenance of skeletal tissue homeostasis. To our knowledge, this is the first report delineating how an m⁶A reader directly targets a senescence-associated gene to orchestrate chondrogenesis. An interesting finding from our in vivo study was that intra-articular injection of YTHDC1-overexpressing hPDLSCs not only improved cartilage integrity but also significantly rescued subchondral bone loss. This suggests that the therapeutic effects may extend beyond the articular surface. We propose that such an effect on bone may be explained through two interrelated mechanisms. First, through paracrine signaling: the engineered hPDLSCs, which exhibit reduced senescence, are likely to secrete a range of trophic factors, exosomes, and immunomodulatory cytokines into the synovial fluid. These molecules could reach the subchondral bone region via preexisting pathological vascular channels that are known to develop in osteoarthritic joints,46 where they may modulate the activity of osteoclasts and osteoblasts. Second, by helping to restore the physiological function of cartilage within the osteochondral unit. In pathological conditions, degraded cartilage releases factors such as VEGF and RANKL, which can promote abnormal bone remodeling.47 By mitigating cartilage degeneration and inflammation, the transplanted cells may attenuate this detrimental signaling. Moreover, improvements in cartilage mechanical properties could contribute to more normalized load distribution across the joint—a known regulator of subchondral bone architecture.48 Thus, intra-articular delivery of rejuvenated hPDLSCs may help establish a microenvironment that supports cartilage in maintaining its regulatory role over subchondral bone homeostasis, potentially leading to the observed structural improvements. Our study has limitations. The precise mechanism by which YTHDC1 recruits the RNA decay machinery to GADD45B transcripts requires further elucidation. Future studies employing cell-type-specific conditional knockout models would provide definitive genetic validation. The long-term safety and efficacy of targeting the YTHDC1–GADD45B axis in vivo also warrant detailed investigation. In conclusion, we have uncovered a previously unappreciated YTHDC1-GADD45B-p53 axis that serves as a critical checkpoint for hPDLSC function. By demonstrating that a single m⁶A reader protein can directly influence a fundamental process like cellular senescence to dictate chondrogenic capacity, our work substantially expands the functional repertoire of the epitranscriptome in adult stem cell biology. We propose that strategies aimed at stabilizing this pathway hold significant promise for regenerating craniofacial and possibly other cartilaginous tissues affected by degeneration and aging. Materials and methods Isolation and culture of hPDLSCs hPDLSCs were isolated from healthy premolars and third molars obtained from informed donors under an approved ethical protocol (Approval No. 2024110411). The periodontal ligament tissues were digested with 3 mg/mL collagenase type I (Sigma) at 37 °C for 45 min. The isolated cells were cultured in α-MEM medium supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin. Cells at passages 3–5 were used in subsequent experiments. Upon reaching 70%–80% confluence at the third passage, the cells were harvested and subjected to flow cytometry analysis for surface marker characterization. The following antibodies were used: CD31, CD34, CD45, CD73, CD90, and CD105 (all from BioLegend, California, United States). Chondrocyte origin and culture For the co-culture experiments, primary articular chondrocytes were isolated from the knee joints of 2-week-old Sprague-Dawley rats. Cartilage tissues were harvested aseptically, minced, and digested with 0.25% collagenase II at 37 °C for 4–6 h. The released cells were collected by centrifugation, washed, and seeded in Dulbecco’s modified Eagle’s medium/F-12 (DMEM/F-12) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 µg/mL streptomycin. Cells were used at passages 2–3 for all co-culture experiments to maintain their phenotypic stability. The use of rat-derived chondrocytes is consistent with the species of the TMJOA animal model, thereby minimizing potential interspecies variability in inflammatory response studies. All procedures involving animals were approved by the Institutional Animal Care and Use Committee of Southwest Medical University (Approval No. 20220701-004) and conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals. RNA extraction, reverse transcription, and qPCR Total RNA was extracted from hPDLSCs using TRIzol reagent (Invitrogen). RNA quality was verified by NanoDrop (A260/A280 ≥ 1.8). Reverse transcription was performed with 1 µg RNA using PrimeScript RT Reagent Kit (Takara). qPCR was carried out using TB Green Premix (Takara) on a QuantStudio 5 system. Reactions were run in triplicate under the following conditions: 95 °C for 30 s, followed by 40 cycles of 95 °C for 5 s and 60 °C for 30 s. Gene expression was normalized to GAPDH and analyzed via the 2–ΔΔCt method. Primer sequences are provided in Table S1. Protein extraction and western blot analysis Cells were lysed using RIPA buffer supplemented with protease and phosphatase inhibitors (Beyotime). Protein concentration was determined using a BCA assay kit (Thermo Fisher). Equal amounts of protein (20 µg per lane) were separated by 10% SDS-PAGE and transferred to PVDF membranes (Millipore). After blocking with 5% non-fat milk for 1 h at room temperature, the membranes were incubated overnight at 4 °C with primary antibodies against YTHDC1、SOX9、COL2A1、GADD45B、P16、P53、P21(1:1 000, Abcam) and GAPDH (1:5 000, Proteintech). Following incubation with HRP-conjugated secondary antibodies (1:5 000, Cell Signaling Technology) for 1 h at room temperature, protein bands were visualized using an ECL detection system (Bio-Rad). Quantification was performed using ImageJ software. Chondrogenic, osteogenic, and adipogenic differentiation Chondrogenic differentiation was induced using a three-dimensional pellet culture system. Cells were centrifuged to form micromass pellets and cultured in chondrogenic induction medium (Cyagen, USA) for 21 days, with medium changes every three days. Osteogenic and adipogenic differentiations were induced using commercially available induction kits (Cyagen, USA) for 14 and 21 days, respectively. Chondrogenesis was confirmed by Alcian Blue staining of sulfated proteoglycans in the pellets. Osteogenic and adipogenic differentiations were verified by Alizarin Red S staining of mineralized nodules and Oil Red O staining of lipid droplets, respectively. Immunohistochemical staining of cartilage pellet sections Pellet samples were fixed in 4% paraformaldehyde, dehydrated, and embedded in paraffin. Sections (5 μm thickness) were deparaffinized and rehydrated. Antigen retrieval was performed using citrate buffer. Endogenous peroxidase activity was quenched with 3% H₂O₂. Sections were blocked with 10% normal goat serum and incubated overnight at 4 °C with primary antibodies against COL2A1、YTHDC1 and SOX9 (1:200, Abcam). After washing, sections were incubated with HRP-conjugated secondary antibodies, developed with DAB, and counterstained with hematoxylin. Images were captured using a light microscope. Quantification of histological staining intensity Briefly, staining intensity for Safranin O (proteoglycans) and Alcian Blue (glycosaminoglycans) was quantified using ImageJ (Fiji). After capturing 3–5 representative fields under consistent lighting, the specific stain was isolated via color deconvolution. The mean gray value within the manually outlined cartilage area was measured, background-subtracted using an unstained region, and averaged across fields to generate the reported arbitrary units (AU), which correlate with matrix component content. For H&E-based assessment, standardized semi-quantitative scoring (e.g., OARSI) was applied by two blinded observers. Lentiviral transduction and siRNA transfection Lentiviral vectors designed for YTHDC1 overexpression and knockdown were synthesized and packaged by Heyuan (Shanghai, China). Cells were seeded in 6-well plates at a density of 2 × 105 cells per well and cultured overnight to reach 60%–70% confluence prior to transduction. For lentiviral infection, hPDLSCs were incubated with viral supernatant at a multiplicity of infection (MOI) of 50 in complete medium supplemented with 5 μg/mL polybrene (Sigma-Aldrich, USA) to enhance transduction efficiency. After 24 h, the virus-containing medium was replaced with fresh complete medium. Transduction efficiency was evaluated via fluorescence microscopy and Western blotting 72 h post-infection. For siRNA transfection, YTHDC1-specific siRNA and non-targeting scrambled control siRNA (designed and synthesized by Heyuan, Shanghai, China) were transfected into hPDLSCs using Lipofectamine 3000 transfection reagent (Invitrogen, USA) according to the manufacturer’s instructions. Briefly, cells were seeded in 6-well plates and transfected at 60%–70% confluence. The siRNA-Lipofectamine complexes were prepared in Opti-MEM reduced serum medium (Gibco, USA) and added to the cells. After 6 h of incubation, the transfection mixture was replaced with standard culture medium. Knockdown efficiency was assessed 48 h post-transfection by quantitative real-time PCR and Western blot analysis. Integrated analysis of mRNA-seq and RIP-seq ① Experimental Design: Use of YTHDC1-overexpressing (YTHDC1-OE) and empty vector (EV) control hPDLSCs, with three biological replicates per group. ② DEG Identification: A complete pipeline from quality control (FastQC, Trimmomatic) and alignment (HISAT2) to differential expression analysis using DESeq2. Significant DEGs were defined as those with Padj < 0.05 and |log₂FC | > 0.585 (~1.5-fold change). The full DEG list is provided in Supplementary Table S2. ③ Logical Progression: Analysis now logically proceeds from reporting the DEG list to KEGG pathway enrichment (Padj < 0.05) using clusterProfiler, which identified the senescence and p53 pathways. ④ RIP-seq & Integration: Details on RIP-seq peak calling (MACS2, Padj < 0.05) and the intersection criteria (downregulated in RNA-seq and enriched in RIP-seq) that identified GADD45B as a high-confidence target. RNA Pull-down assay The direct interaction between YTHDC1 protein and GADD45B mRNA was validated by an RNA pull-down assay. Briefly, a biotinylated GADD45B RNA probe was synthesized by in vitro transcription. Cell lysates from hPDLSCs were incubated with the probe or a negative control RNA, followed by capture with streptavidin magnetic beads. After extensive washing, the bead-bound proteins were eluted and analyzed by western blotting using an anti-YTHDC1 antibody. RNA Immunoprecipitation (RIP) and methylated RNA immunoprecipitation quantitative PCR (MeRIP-qPCR) RNA immunoprecipitation (RIP) assays were conducted using the Magna RIP™ RNA-Binding Protein Immunoprecipitation Kit (Millipore, USA) according to the manufacturer’s instructions. Briefly, hPDLSCs were lysed and the supernatant was incubated with magnetic beads conjugated with anti-YTHDC1 antibody (Abcam, dilution 1:50) or normal rabbit IgG as a negative control. After extensive washing, the immunoprecipitated RNA was extracted and subjected to subsequent quantitative analysis. For MeRIP-qPCR experiments, the procedure was performed based on previously established methods with minor modifications. Briefly, total RNA was isolated and fragmented. The fragmented RNA was incubated with anti-m6A antibody (Synaptic Systems, dilution 1:100) conjugated to protein A/G magnetic beads. IgG was used as an immunoprecipitation control. After washing, the bound RNA was eluted and purified. Enrichment of m6A-modified transcripts was quantified by quantitative real-time PCR using specific primers targeting genes of interest. All experiments were performed in three independent biological replicates. Animal model and cell transplantation A unilateral anterior crossbite (UAC) model was established in 8-week-old male Sprague-Dawley rats (weight range: 220–250 g) as previously described. Briefly, a custom orthodontic appliance was fitted to the maxillary incisors to induce malocclusion. Rats were randomly assigned to six experimental groups (n = 6 per group). Interventions were initiated at the fourth week following UAC induction. Prior to transplantation, hPDLSCs were preconditioned in chondrogenic induction medium (Cyagen, USA) for 3 days to prime their chondrogenic differentiation potential. Human PDLSCs were used in this xenogeneic transplantation model based on their well-documented low immunogenicity and immunomodulatory capacity, which permits their short-to-medium term survival and function in immunocompetent rodents without immunosuppression, as commonly employed in proof-of-concept studies of MSC-based therapies. The experimental groups were designed as follows: ① Control group (CON): No UAC induction and no treatment; ② Vehicle control group (TMJOA + PBS): UAC-induced rats receiving intra-articular injection of phosphate-buffered saline (PBS); ③ YTHDC1 overexpression group (TMJOA + YTHDC1-OE hPDLSCs): UAC-induced rats injected with lentivirus-mediated YTHDC1-overexpressing human periodontal ligament stem cells (hPDLSCs); ④ Negative control group (TMJOA + YTHDC1-NC hPDLSCs): UAC-induced rats injected with empty vector-transduced hPDLSCs; ⑤ Wild-type rescue group (TMJOA + YTHDC1-OE hPDLSCs + GADD45B-WT-OE): UAC-induced rats co-injected with YTHDC1-overexpressing and GADD45B wild-type-overexpressing lentiviral-modified hPDLSCs; ⑥ Mutant rescue group (TMJOA + YTHDC1-OE hPDLSCs + GADD45B-MUT-OE): UAC-induced rats co-injected with YTHDC1-overexpressing and GADD45B mutant-overexpressing lentiviral-modified hPDLSCs. After 8 weeks of UAC induction, rats were euthanized, and tissue samples were harvested for subsequent analysis. All experimental procedures were approved by the Institutional Animal Care and Use Committee of Southwest Medical University. (Approval No.20220701-004) and conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals. Micro-CT and histological analysis Four weeks post-transplantation, the rats were euthanized and Temporomandibular joint (TMJ) specimen were harvested. The collected samples were subsequently scanned using a high-resolution micro-CT system (SCANCO Medical, Switzerland) for detailed morphological analysis. For histological evaluation, tissue samples were fixed in 4% paraformaldehyde, decalcified, embedded in paraffin, and sectioned at 5 μm thickness. Sections were stained with Hematoxylin and Eosin (H&E), Safranin O, and Sirius Red according to established protocols. Immunohistochemical staining was performed using specific primary antibodies followed by appropriate secondary antibodies, with DAB as the chromogen. All stained sections were imaged under a light microscope (Nikon, Japan). Quantification of Histological Staining Intensity: Briefly, staining intensity for Safranin O (proteoglycans) and Alcian Blue (glycosaminoglycans) was quantified using ImageJ (Fiji). After capturing 3–5 representative fields under consistent lighting, the specific stain was isolated via color deconvolution. The mean gray value within the manually outlined cartilage area was measured, background-subtracted using an unstained region, and averaged across fields to generate the reported arbitrary units (AU), which correlate with matrix component content. For H&E-based assessment, standardized semi-quantitative scoring (e.g., OARSI) was applied by two blinded observers. Statistical analysis Data are presented as mean ± SEM. Comparisons were made using one-way ANOVA or two-tailed Student’s t test. P < 0.05 was considered significant. Supplementary information Supplementary materials Dataset 1 Dataset 2 Dataset 3 Dataset 4 Dataset 5 Dataset 6 Dataset 7 Table S1 Table S2 Acknowledgements This work was supported by National Natural Science Foundation of China (82370938), Science & Technology Department of Sichuan Province (2024NSFSC2087), Open Project of State Key Laboratory of Oral Diseases (SKLOD2025OF05), Science and Technology Project of Health Commission of Sichuan Province (24WXXT11), Scientific and Technological Project of Luzhou (2025MYF002, 2025MYF024), 2023 Key Project of The Affiliated Stomatological Hospital of Southwest Medical University (2023Z02) and Stomatological Special Fund of Southwest Medical University (2024KQZX08). Author contributions D.T. designed and performed the experiments, analyzed the data, wrote the manuscript; Q.K.T. reviewed and revised the manuscript; Q.N.Y. performed data analysis and interpretation; L.W.Y. contributed to help conduct animal experiments; X.M.L. and Q.L.L. contributed to data collection and interpretation; J.G.X. and J.L.S. directed the project, provided financial support, critically revised manuscript, and gave final approval. Data availability All data supporting the findings of this study are available within the paper and its Supplementary Information. Competing interests The authors declare no competing interests. Footnotes These authors contributed equally: Dan Tan, Qianke Tao Contributor Information Jinlin Song, Email: songjinlin@hospital.cqmu.edu.cn. Jingang Xiao, Email: xiaojingang@swmu.edu.cn. Supplementary information The online version contains supplementary material available at 10.1038/s41368-026-00441-8. References Associated Data Supplementary Materials Supplementary materials Dataset 1 Dataset 2 Dataset 3 Dataset 4 Dataset 5 Dataset 6 Dataset 7 Table S1 Table S2 Data Availability Statement All data supporting the findings of this study are available within the paper and its Supplementary Information.